Philips debuts connected management solution using cloud-based data to support treatment adherence for sleep and respiratory patients

June 14, 2016

  • New Patient Adherence Management Service (PAMS) helps to increase CPAP therapy adherence rates by 49 percent on average1
  • Builds on commitment and longstanding expertise to effectively engage, manage and improve patient care with connected solutions

 

Denver, Colorado – Philips Respironics, a division of Royal Philips (NYSE: PHG, AEX: PHIA), today introduced Patient Adherence Management Service (PAMS), which will support new patients’ transition to sleep therapy. PAMS is on display during this year’s SLEEP 2016 event (June 11-15) along with several leading health solutions that demonstrate Philips’ commitment to expanding its successful connectivity model in sleep and respiratory care. With more than 10 years of cloud-based data sharing experience and analytics for more than 7 million patient lives, Philips has a long history of leading new innovation in informatics to help patients sleep and breathe better.

 

PAMS utilizes Philips Respironics’ EncoreAnywhere software, DreamStation PAP therapy devices, Philips’ portfolio of masks and the DreamMapper patient engagement application. PAMS is a concrete example of how Philips’ connected care management solutions help provide customers with insight and the necessary tools to enhance overall patient care.

 

“For years, Philips Respironics has provided innovative solutions to help patients with sleep and breathing disorders, always leveraging technology to make therapy feel as natural as possible,” said Dr. Aloia, Vice President and Global Lead, Behavior Change, Philips. “Our innovations are connected to intuitively work together at every phase of the health continuum and are designed to enable exceptional outcomes in patient adherence. With this new connected management service, our goal is to help patients fully engage with and adapt to their therapy, ultimately helping them live healthier lives.”

 

Better sleep therapy adherence and patient satisfaction

Developed as a result of input from homecare providers looking for additional support to improve sleep patient adherence, Philips’ Patient Adherence Management Service has been shown to boost adherence rates of CPAP patients by an average of 49 percent2. PAMS leverages Philips’ deep knowledge of sleep apnea and the data of millions of patients who have been managed by EncoreAnywhere, the world’s most widely-used patient compliance management system.

 

PAMS has shown to improve adherence rates up to 24 percent within the first 90 days, and at least 16 percent or more in the first 30 days of therapy[3]. PAMS aims to not only help improve compliance rates, but improve the experience of new patients attempting to adapt to therapy. Key components of the PAMS program, include:

  • Patient Outreach Protocol: This includes personalized calls, emails and texts to deliver education, motivational reminders and support from sleep coaches and respiratory therapists trained in health behavior change;
  • EncoreAnywhere Software and Predictive Modeling: PAMS uses this software for workflow and communications with homecare providers, helping to identify patients struggling with therapy adoption and personalize coaching;
  • Dream Family Connectivity: PAMS uses the DreamStation PAP device (connected via cell or Wi-Fi), Philips’ masks and the DreamMapper patient engagement app.

 

Solutions that address adherence, provide efficiencies

PAMS is just the latest in applied-data solutions from Philips that build on the company’s longstanding commitment to creating solutions that help better manage sleep and respiratory conditions and improve patient care. Philips’ track record in providing connected solutions can be seen in additional technologies that are on-site during SLEEP 2016, including the Care Orchestrator care management application. The first-of-its-kind connected health technology for sleep and respiratory conditions, Care Orchestrator allows patients to stay connected to their care teams throughout the course of therapy. It is the next generation of EncoreAnywhere, and enables data, clinical management workflow, informatics and intelligence for providers, payers and patients within a single cloud-based platform. A full range of Philips sleep and respiratory devices, including DreamStation BiPAP ASV and BiPAP AVAPS, Trilogy, EverFlo, SimplyGo and iNeb, are planned to connect to Care Orchestrator and tie into the Philips HealthSuite cloud platform.

 

Visitors can view a demonstration of PAMS at the Philips Respironics booth 101. Additionally, during the show, Philips Respironics’ employees and partners presented the following:

  • “Adherence to Positive Airway Pressure Therapy with a Structured Adherence Program” 
    William Hardy, RRT, presented a Poster Abstract on Clinical Sleep research that analyzed the impact of a structured patient adherence management program on patient adherence to CPAP therapy. The session was held on Sunday, June 12, 5:00 p.m. – 7:00 p.m. in the Poster Hall.
  • “Bringing Behavior Change Psychology into Digital Solutions at Philips Respironics” 
    Mark Aloia, PhD, spoke about the use of structured patient adherence programs and technology to improve patient adherence in CPAP therapy. The session was held on Monday, June 13, 12:30 p.m. at Philips Booth 101.

 

For updates on Philips’ presence at SLEEP 2016, visit http://philips.to/1sdjDqI. For more information on Philips advanced solutions for sleep and respiratory care and updates from the show, follow @PhilipsResp and the Philips Respironics Facebook.

 


[1] Retrospective study using 2014 -2016 EncoreAnywhere data from 12 Home Care Providers that used PAMS for at least six months. CMS Compliance definition - minimum of 4 hours of use over 70% of the nights during a consecutive 30 day period within the first 90 days of use.

[2] Retrospective study using 2014 -2016 EncoreAnywhere data from 12 Home Care Providers that used PAMS for at least six months. CMS Compliance definition - minimum of 4 hours of use over 70% of the nights during a consecutive 30 day period within the first 90 days of use.

[3] Retrospective study using 2014 -2016 EncoreAnywhere data from 12 Home Care Providers that used PAMS for at least six months. CMS Compliance definition - minimum of 4 hours of use over 70% of the nights during a consecutive 30 day period within the first 90 days of use.

For further information, please contact:

Alicia Cafardi

Philips

alicia.cafardi@philips.com

724-387-4439

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.